pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 30·1 min read
save

Included Health to acquire Firefly Health, signaling push into alternative health plans

Jul 30, 2026·read at Endpoints ↗DealPositive

Included Health announced it will acquire Firefly Health, a move aimed at expanding its presence in the emerging alternative health plan market.

The acquisition reflects the company's belief that alternative plans, which differ from traditional PPOs, HMOs, and high‑deductible options, will play a larger role in how employees receive care.

Industry observers see the transaction as a significant investment in a segment that could reshape employer‑provided health benefits.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Betting big on alternative health plans”

read at Endpoints ↗
74 words · retrieved Jul 30
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoAspen Neuroscience lands $141M IPO, while Bambusa secures $169MEndpoints
  • 14h agoFor Lilly, cash-pay is key in the US and, increasingly, abroadEndpoints
  • 15h agoBristol Myers defends pipeline, reinforces later-stage BD interestEndpoints
  • 15h agoR&D chief Dean Li says Merck outflanked rivals with its sac-TMT cancer programEndpoints
  • 18h agoUK lands £500M in biopharma pledges; Teva to shutter New Jersey siteEndpoints